These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39366869)

  • 1. Fibronectin 1 serves as a potential diagnostic, immunological and prognostic biomarker for glioblastoma patients.
    Shen A; Dai L; Zhou D; Zhou P
    Asian J Surg; 2024 Oct; ():. PubMed ID: 39366869
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
    Kabir F; Apu MNH
    Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker.
    Meng W; Jiang Z; Zhang X; Cai B; Ma L; Guan Y
    Comput Math Methods Med; 2022; 2022():3119721. PubMed ID: 36466552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression.
    Ghulam Muhammad AK; Candolfi M; King GD; Yagiz K; Foulad D; Mineharu Y; Kroeger KM; Treuer KA; Nichols WS; Sanderson NS; Yang J; Khayznikov M; Van Rooijen N; Lowenstein PR; Castro MG
    Clin Cancer Res; 2009 Oct; 15(19):6113-27. PubMed ID: 19789315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
    Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
    J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
    Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
    Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGAP2-AS1 serves as an oncogenic lncRNA and prognostic biomarker in glioblastoma multiforme.
    Tian Y; Zheng Y; Dong X
    J Cell Biochem; 2019 Jun; 120(6):9056-9062. PubMed ID: 30525219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DGCR5 suppresses the EMT of pediatric primary glioblastoma multiforme cell and serves as a prognostic biomarker.
    Yang F; Huang YL
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10024-10034. PubMed ID: 31799672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients.
    Uzum Y; Salman T; Oflazoglu U; Yildiz Y; Varol U; Aysin M; Kucukzeybek Y; Alacacioglu A; Tarhan MO
    Bratisl Lek Listy; 2024; 125(8):463-467. PubMed ID: 38989745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKBIP might be a potential prognostic biomarker for glioblastoma multiforme.
    Chen H; Liang B; Luo X; Zhang W; Song X; Lan H; Yue Q; Xie J; Zhang M
    Int Immunopharmacol; 2023 May; 118():110030. PubMed ID: 36989893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of T-cell exhaustion-related gene signature for predicting prognosis in glioblastoma multiforme.
    Liu YH; Jin HQ; Liu HP
    J Cell Mol Med; 2023 Nov; 27(22):3503-3513. PubMed ID: 37635346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
    Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
    Kefayat A; Amouheidari A; Ghahremani F; Alirezaei Z
    Cancer Med; 2021 Aug; 10(15):5154-5162. PubMed ID: 34250760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarkers for glioblastoma multiforme.
    Quddusi A; Shamim MS
    J Pak Med Assoc; 2019 Jun; 69(6):913-914. PubMed ID: 31201406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Expression of Fibronectin 1 Predicts a Poor Prognosis in Glioblastoma.
    Wu S; Liu C; Wei X; Nong WX; Lin LN; Li F; Xie XX; Liao XS; Luo B; Zhang QM; Xiao SW
    Curr Med Sci; 2022 Oct; 42(5):1055-1065. PubMed ID: 36260267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for a diagnostic/prognostic biomarker for the brain cancer glioblastoma multiforme by 2D-DIGE-MS technique.
    Banerjee HN; Mahaffey K; Riddick E; Banerjee A; Bhowmik N; Patra M
    Mol Cell Biochem; 2012 Aug; 367(1-2):59-63. PubMed ID: 22547198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSPAN4 is a prognostic and immune target in Glioblastoma multiforme.
    Zheng Y; Lang Y; Qi B; Wang Y; Gao W; Li T
    Front Mol Biosci; 2022; 9():1030057. PubMed ID: 36685274
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the prognostic value of CD44 in glioblastoma multiforme.
    Wei KC; Huang CY; Chen PY; Feng LY; Wu TW; Chen SM; Tsai HC; Lu YJ; Tsang NM; Tseng CK; Pai PC; Shin JW
    Anticancer Res; 2010 Jan; 30(1):253-9. PubMed ID: 20150644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM).
    Amer RG; Ezz El Arab LR; Abd El Ghany D; Saad AS; Bahie-Eldin N; Swellam M
    J Neurooncol; 2022 Jul; 158(3):435-444. PubMed ID: 35668225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.